Cannula device

Information

  • Patent Grant
  • 8062250
  • Patent Number
    8,062,250
  • Date Filed
    Thursday, December 23, 2004
    19 years ago
  • Date Issued
    Tuesday, November 22, 2011
    12 years ago
Abstract
A cannula device for infusion sets is provided. The cannula device includes a housing and at least one membrane mounted to the housing and adapted for receiving a piercing member of a connector. The cannula device further includes a cannula mounted to the housing. The cannula device is adapted to removably attach to a base part of an infusion set. The cannula device can receive the piercing member from a first receiving direction and from a second receiving direction different from the first receiving direction, providing fluid communication between the piercing member and the cannula mounted to the housing.
Description
FIELD OF THE INVENTION

The present invention relates to a cannula device, especially for use in infusion sets. The cannula device may be used in conjunction with various versions of infusion sets.


BACKGROUND

Normally, an infusion set for intermittent or continuous administration of a therapeutic substance, such as insulin, is in the form of a two-part device.


A traditional infusion set comprises a base part having a cannula for insertion into a patient where the base part has means for receiving a connector cannula extending from a connector and for bringing the connector cannula into fluid communication with the cannula of the base part. Often, the connector needle is in fluid communication with a drug delivery device, such as an insulin pump.


Different kinds of infusion sets are described in WO 02/068014 A2, EP 0 956 879 A1, U.S. Pat. No. 5,522,803, U.S. 2003/0225373 A1 and WO 03/026728 A1.


U.S. 2003/0176852A1 discloses an infusion set in which a base part comprises a pivoting member, the base part comprising a cannula for insertion into a patient and pivoting member has an inner cavity with one receiving end adapted to receive an inserter needle or a piercing member and two connecting ends (316I and 320) for further connection with the cannula of the base part. During insertion, the pivoting member is positioned orthogonally to the base part and an inserter needle penetrates a membrane in the receiving end. The needle passes through a canal and through the first connecting end into the cannula which then can be inserted. After insertion, the needle is removed and the pivoting member is connected with a connector. The connector and the pivoting member are connected from the same direction as the connection between the pivoting member and the inserter. The pivoting member is then turned in order for the second connecting end to align with the cannula. This device has the drawback that it is very sensitive to movement of the pivoting member since a small turning will close off the delivery of drugs.


WO 02/094352 A2 discloses an infusion set having a base part that can receive an insertion needle from one direction and a connector needle from a second direction. This design does not allow the patient to choose the direction he/she wants to connect the connector with the base part.


In the infusion sets described above, the construction of the cannula and the means for providing fluid communication between the cannula and the cannula from the connector are unique for each set. Normally each infusion set also utilizes a specific set of guiding and/or locking members and thus allows only for a specific connector to engage with the base part.


It would be highly desirable from both a production point of view and practical use if a universal part having a cannula and means adapted to receive the cannula from the connector and fitting to most/all common infusion sets available. Aspects of the present invention are intended to cover both infusion sets as described above and variants thereof when such a universal part is used therein.


Furthermore, in the infusion sets described above, both the connector and the base part have to be substituted if the patient wishes to change to a different base part. It would be advantageous if different types of connectors could be used with the same base part and different types of base parts could be used with the same connector. It would also be advantageous if connection from different angles would be possible.


BRIEF SUMMARY

An object of the present invention is therefore to provide a cannula device which can be used as a component in most if not all common infusion sets and which allows for connection from more than one direction.


According to one aspect of the present invention, a cannula device for infusion sets is provided. The cannula device includes a housing and at least one membrane mounted to the housing and adapted for receiving a piercing member of a connector. A cannula is mounted to the housing. The cannula device is adapted to removably attach to a base part of an infusion set. The cannula device can receive the piercing member from a first receiving direction and from a second receiving direction different from the first direction, providing fluid communication between the piercing member and the cannula.


According to another aspect of the present invention, a cannula device for mounting to a base part of an infusion set is provided. The cannula device includes a housing and at least one membrane adapted to receive a piercing member of a connector and a cannula mounted to the housing. The cannula device is adapted to removably attach to a base part of an infusion set. The cannula device can receive the piercing member from a first receiving direction and from a second receiving direction being different from the first direction providing fluid communication between the piercing member and the cannula.


According to another aspect of the present invention, an infusion set is provided. The infusion set includes a base part and a cannula device removably connected to the base part. The cannula device includes a housing having at least one membrane secured thereto, and a cannula mounted to the housing. The cannula device is adapted to receive a piercing member of a connector from a first receiving direction and from a second receiving direction different from the first direction, providing fluid communication between the piercing member and the cannula of the cannula device.


An advantage of the cannula device of the present invention is that it can be used as a key component in infusion sets with both parallel and orthogonal connection between the connector and the base part seen relative to the skin of the carrier. Thus this key component can be mass produced and be used as a component in a series of desired designs of the infusion sets. This results in lower manufacturing costs, a more flexible production line and a more flexible product.


Advantages of the present invention will become more apparent to those skilled in the art from the following description of the preferred embodiments of the invention which have been shown and described by way of illustration. As will be realized, the invention is capable of other and different embodiments, and its details are capable of modification in various respects. Accordingly, the drawings and description are to be regarded as illustrative in nature and not as restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS

The cannula device will be described in further detail with reference to the figures.



FIG. 1 is a perspective view of an embodiment of the cannula device of the present invention;



FIG. 2 is an enlarged view of the housing of the cannula device shown in FIG. 1;



FIG. 3 is a sectional view of the cannula device shown in FIG. 2;



FIG. 4 is a perspective view of the cannula device coupled with an inserter;



FIG. 5 is a perspective view of the cannula device mounted in a base part of an infusion set;



FIG. 6 is an exploded perspective view of the cannula device mounted in a base part;



FIG. 7 is a top view of the cannula device mounted in a base part and encapsulated by protecting members;



FIG. 8 is an exploded top perspective view showing the cannula device mounted in a base part in which a cannula is essentially orthogonal to the main plane of the base part;



FIG. 9 is a side view of an inserter coupled with the embodiment shown in FIG. 8;



FIG. 10 is a perspective view showing the mounting of the cannula device in the base part;



FIG. 11 is an exploded side view showing another position for the cannula device mounted in the base part;



FIG. 12 is an exploded view showing the embodiment of FIG. 11 from a different angle;



FIG. 13 is an exploded view of the cannula device mounted in a second type of base part including an inserter and a protective member;



FIG. 14 is an exploded view of the cannula device mounted in the base part shown in FIG. 13 wherein the cannula device is mounted in an orthogonal direction;



FIG. 15 is a top perspective view of the cannula device in the base part with a protective member;



FIG. 16 is a sectional view of the embodiment shown in FIG. 15;



FIG. 17 is an exploded view of the embodiment shown in FIG. 14 having a different protective member;



FIG. 18 is a perspective view of an embodiment of the cannula device, the base part and an inserter;



FIG. 19 is a perspective view of the embodiment shown in FIG. 18 with the inserter inserted in an orthogonal direction;



FIG. 20 is a perspective view of the embodiment shown in FIG. 18 with the inserter removed;



FIG. 21 is a top perspective view of the embodiment shown in FIG. 18 with the protective member engaged with the base part;



FIG. 22A shows the cannula device of FIG. 1;



FIGS. 22B-D show the cannula device of FIG. 22A having various protective members;



FIG. 23A-D show side views of the embodiments shown in FIGS. 22A-D;



FIG. 24A-D show top views of the embodiments shown in FIGS. 22A-D;



FIG. 25 is a perspective view of an embodiment of the present invention having a protective member;



FIG. 26 is a sectional view of the embodiment shown in FIG. 25;



FIG. 27 is an exploded view of an embodiment of the present invention including adhesive layer;



FIG. 28 is an exploded bottom view of the embodiment shown in FIG. 27;



FIG. 29A is an another embodiment of the cannula device of the present invention;



FIG. 29B is a partial sectional view of the embodiment shown in FIG. 29A;



FIG. 30A is a front perspective view of the cannula device and a connector;



FIG. 30B is top perspective view of the embodiment shown in FIG. 30A;



FIG. 31A is an exploded top view of the cannula device, the base and the connector;



FIG. 31B is a perspective view of the cannula device and base part of the embodiment shown in FIG. 31A;



FIG. 32A is a sectional view of the embodiment shown in FIG. 31A;



FIG. 32B is a sectional view of the embodiment shown in FIG. 31B;



FIG. 32C is a side view of the embodiment shown in FIG. 31B;



FIG. 32D is a top view of the embodiment shown in FIG. 31B;



FIG. 33A is a perspective view of the cannula device shown in FIG. 31B with the cannula device in an orthogonal direction;



FIG. 33B is a perspective view of the cannula device shown in FIG. 31A with the cannula device in an orthogonal direction;



FIGS. 33C and D show top views of the embodiments shown in FIGS. 33A and B respectively;



FIG. 34A is a front perspective view of an embodiment of the cannula device;



FIG. 34B is a perspective view of an embodiment of the cannula device, the base part and the adhesive layer;



FIG. 35 is a sectional view of the embodiment shown in FIG. 34B;



FIGS. 36A-E are top and perspective views of an embodiment of the present invention;



FIG. 37A is a top perspective view of the cannula device and the connector showing the cannula in an orthogonal direction;



FIG. 37B is a side perspective view of the embodiment shown in FIG. 37A;



FIG. 37C is a top view of the embodiment shown in FIG. 37A;



FIG. 38A is a side perspective view of the cannula device and the connector showing the cannula in a parallel direction;



FIG. 38B is a top view of the embodiment shown in FIG. 38A;



FIG. 39 is a perspective view showing an inserter with the cannula device;



FIGS. 40A and B are perspective views showing the cannula device mounted in the connector at different positions;



FIGS. 41A and B are sectional views of the embodiment shown in FIGS. 41A and B respectively;



FIGS. 42A and B are side views of the embodiment shown in FIGS. 41A and B respectively;



FIG. 43 is a sectional view of an embodiment of the cannula device of the present invention showing the connector in communication with the cannula;



FIG. 44 is a top perspective view of the cannula device, base part and connector showing the locking members;



FIG. 45 is a top view of an embodiment of the present invention;



FIG. 46 is a top perspective view of the cannula device, base part and inserter;



FIG. 47 is a perspective view of the cannula device and the inserter mounted on the base part in an orthogonal direction.



FIG. 48 shows the inserter that can be mounted on the cannula device;



FIG. 49 is a perspective view of an embodiment of the present invention showing an angled base part;



FIG. 50 is a top view of the cannula device mounted in an angled base part;



FIG. 51 is a sectional view of the embodiment shown in FIG. 50;



FIG. 52 is a front perspective view of the embodiment shown in FIG. 50;



FIG. 53 is a top perspective view of the embodiment shown in FIG. 50;



FIG. 54 is a perspective view of the embodiment shown in FIG. 50;



FIG. 55 is a perspective view of the embodiment shown in FIG. 50;



FIG. 56 is a perspective view of the embodiment shown in FIG. 50;



FIG. 57 is a front perspective view of the embodiment shown in FIG. 50;



FIG. 58 is an exploded perspective view of another embodiment of the present invention;



FIG. 59 is an exploded perspective view of the cannula device and the base part shown in FIG. 58;



FIG. 60 is a perspective view of the embodiment shown in FIG. 59 with the cannula device in an orthogonal direction;



FIG. 61 is a perspective view of the embodiment shown in FIG. 60 with the cannula device in a parallel direction;



FIG. 62 is an exploded perspective view of the embodiment shown in FIG. 61;



FIG. 63 is an exploded perspective view of the embodiment shown in FIG. 61; and



FIG. 64 is a sectional view of the cannula device shown in FIG. 58.





DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 shows a first embodiment of the present invention. In this embodiment, the cannula device 1 includes a housing 2 and a membrane 3 which together define a cavity 6 being adapted to receive a piercing member extending from a connector. A cannula 4 is mounted in the housing 2 and is in fluid communication with the cavity 6. The membrane 3 may have an oval or elongated shape covering at least a portion of two sides 8, 10 of the cannula device 1. Alternatively, the membrane 3 may cover at least a portion of one or more sides other than the two sides 8, 10. The membrane 3 may also be configured in an alternative shape, for example, but not limited to, circular, rectangular, triangular and others. This allows for connection with a connector from more than one angle. The membrane 3 is shown as a single membrane that curves around the cavity 6. Alternatively, more than one membrane may be provided for entry of a piercing member in different receiving directions as described below.


In the embodiment shown in FIG. 1, guiding members 5 are provided on the housing 2, thus guiding the connection with a device such as the connector, the inserter, or both. This helps ensure that the cannula from the connector, the connector needles, or both, properly align as described below. As shown in FIGS. 1 and 2, and described below, the guiding members 5 may guide connection from at least two angles being essentially orthogonal to each other.



FIG. 2 shows the cavity 6 defined by the housing 2 and the membrane 3. The cavity 6 may be in fluid communication with the cannula 4. As shown, a pair of guiding members 5 extends from the housing 2, opposite each other on sides 9, 11 of the housing 2. Each guiding member 5 may include a pair of elongate rail members 12 adapted to slidably engage with a device such as a connector or an inserter as described below. Each rail member 12 may further include a notch 14 defined in the rail member 12 for removably engaging another or the same device. Additional guiding members 5 are possible for removable engagement with the device such as the connector, for example from an infusion set, or an inserter, as will be apparent to one of skill in the art.


A sectional view of the cannula device 1 shown in FIG. 3 shows the cavity 6 in further detail. The cavity 6 defines a chamber 16 which is in fluid communication with the cannula 4. An piercing member (such the piercing member 580, 680 described below) can penetrate the membrane 3 at any position on the membrane 3 and communicate with the chamber 16. Thus, the piercing member such as a piercing member may be in fluid communication with the cannula 4 of the device 1, and making it possible to connect the connector to the cannula device 1 from different angles. As shown in FIG. 3, the cannula device 1 may further include entry channels 17 and 19 of the cannula 4. Entry channels 17 and 19 may be in fluid communication with the chamber 16 for reception of a therapeutic substance through the piercing member. Alternatively, the entry channels 17 and 19 may directly receive the piercing member for delivery of the therapeutic substance as described below.


As shown in FIG. 4, the cannula device 1 is connected to an inserter 50. A needle 51 extends from the inserter 50, penetrating the membrane 3 at a first position and extending out through the cannula 4. The inserter 50 is used to place the cannula 4 of the device 1 subcutaneously in the patient. After insertion, the inserter 50 is removed and the cannula 4 is left in the patient for delivery of a therapeutic substance and later withdrawal, for example, when a base part (shown in FIG. 5), the cannula device 1, or both, are removed. FIG. 4 shows that the inserter 50 can be connected to the cannula device 1 from a first insertion direction 18 that may be generally parallel to or aligned with the axis 103 of the cannula 4. A portion of the membrane 3 remains accessible and thus illustrates that it is possible to connect to a connector from a second direction 20 which is different from the first direction 18. As shown, there is approximately a 90° angle between the two directions 18, 20. The first direction 18 and the second direction 20 may be predetermined by the location of the entry chambers 17 and 19 for direct reception of the piercing member. Alternatively, any reception direction may be used with the chamber 16 that allows fluid communication between the piercing member and the cannula 4 of the cannula device for delivery of the therapeutic substance. By way of example, additional angles between the first direction 18 and the second direction 20 are possible. Preferably, the angle between the first direction 18 and the second direction 20 is in the ranges from about 5o to about 175o, more preferably from about 30o to about 150o. Preferably, the angle between the first direction 18 and the second direction 20 is at least about 45o, more preferably about 60o, 75o, 85o most preferably about 90o. One of skill in the art will understand that additional connection directions are possible and from many different angles.


As shown in FIG. 5, the cannula device 1 assembles into a base part 100 of an infusion set 90. In this embodiment, the base part 100 includes base guiding members 101 which fit together with the guiding members 5 mounted on the housing 2 of the cannula device 1. The guiding members 5 on the cannula device 1 may be used to guide and align the cannula device 1 into the base guiding members 101 of the base part 100 and to guide the connection to a connector. An opening 102 in a portion of the base guiding members 101 of the base part 100 allows for connection of the guiding members 5 of the cannula device 1 or a device, such as a connector or an inserter from a second and different direction 20 than the first direction 18 which is parallel to the axis 103 of the cannula 4. The guiding members 5 may be elongated rectangular rails, as shown in this embodiment, or pins, or other types of known alignment mechanisms.


Protecting members 104, 105 are also shown in FIG. 5. The protecting members 104, 105 secure and at least partially enclose, and cover the cannula device 1 on a plurality of sides. The protecting member 105 includes guiding arms 106 and locking arms 107 similar to guiding and locking arms that may be provided on a connector. Exemplary engagement of the locking arms of a connector with an infusion set is described in detail in U.S. Pat. No. 5,522,803 which is incorporated by reference herein in its entirety. The guiding arms 106 are adapted to slidably fit with mating openings 110 formed in the inserter 50 as shown in FIGS. 5 and 6.



FIG. 6 illustrates an alternative, perspective view of the embodiment shown in FIG. 5. Alternatively, the guiding arms 106 may slidably fit with the guiding members 101 of the base 100 as shown in FIG. 8 showing the inserter 50 removed. The locking arms 107 may releasably engage openings 114 formed in the base 100. The releasable engagement of the cannula device 1 with the base part 100 allows for exchange of the base part 100 and the cannula device 1. For example, but not limited to the following, the cannula device 1 may be removed from the base part 100 by sliding the cannula device 1 out of the base part 100. Another cannula device 1 may be slid into the same base part 100 using the same guiding arms 106 of the base part 100. An advantage of the present invention is that the same base part may be reused several times by the patient, thus saving medical expenses. Additionally, the exchangeable cannula device and the base part allow for the use of different cannula devices in the same base part, for example, but not limited to, having a different size cannula 4 with the cannula device 1, i.e., the length or the diameter of the cannula 4. This exchange allows the infusion sets to be configured in sets that are tailored for the patient using these modular components.



FIG. 7 illustrates the cannula device 1 releasably mounted on the base part 100 and the cannula device 1 and the base 100 are capped by protecting members 104 and 105.



FIG. 8 shows the cannula device 1 mounted in the base part 100 in an alternative position to that shown in FIGS. 5-7. In particular, the cannula device 1 is mounted in the second direction 20 wherein the cannula 4 is mounted on the base part 100 essentially orthogonal to a main plane 118 of the base part 100. The base part 100 includes multiple guiding members 105 and openings 102 to allow removable attachment of the cannula device 1 in at least these multiple orientations. As shown in FIG. 8, the guiding members 5 of the housing 2 releasably fit with the opening 102 on the base part 100. Changing the orientation of the guiding members 5 of the housing 2 with respect to the guiding members 101 and the openings 102 on the base part 100 allows the angle between the cannula 4 and the base part 100 to be changed, which may be desired in certain circumstances. Protecting members 104, 105 may also be engaged with the base member 100 when the guiding members 5 of the housing 2 are slidably received in the openings 102 of the base part 100.


As shown in FIG. 9, in combination with FIG. 8, the inserter 50 including the needle 51 extending through the cannula 4 is connected to the cannula device 1 when the cannula device 1 is slidably received in the opening 102 in the base part 100. The protecting members 104, 105 are also engaged with the base part 100. Alternatively, a connector (for example, a connector 450, 550, 650, described below) may be engaged with the base part 100 in the position shown for the inserter 50 or in the position shown for the protecting member 105 and be connected to the cannula device 1. As shown in FIG. 9, the cannula device 1 and the inserter 50 are engaged with the base part 100 in an orthogonal direction as compared to the parallel direction shown in FIG. 7.


In FIG. 10, the cannula device 1 is mounted in the base part 100 in the first direction 18 where the cannula 4 is substantially parallel with the main plane 118 of the base part 100. The cannula device 1 may be slidably retained in the base part 100 by the friction between the guiding members 5 of the cannula device 1 and the guiding members 101 of the base part 100. The guiding arms 106 of the protecting member 105 may be slidably engaged in an opening 122 formed in the base 100 when the cannula device 1 is engaged with the base 100. The cannula device 1 may also be engaged with the base part 100 using several methods known to one of skill in the art. For example, but not limited to, mechanical means, such as rims, grooves or taps; by adhesives such as glue or by friction such as the cannula device 1 fitting with the opening 102 in the base part 100 and being retained therein by the friction between the sides of the guiding means 5 of the cannula device 1 and the sides of the opening 102. The base part 100 may further include locking members that removably secure the cannula device 1 in the base part 100. In addition, the cannula device 1 may have locking members, such as the engaging notch 14, shown in FIG. 2, for securing the cannula device 1 in the base part 100. The locking members may further include disengagement members for releasing the locking members.



FIGS. 11 and 12 show how the locking arms of the protecting member 105, or alternatively a connector having similar locking arms (as shown in FIGS. 52-57), can engage in openings 107 in the base part 100. The cannula 4 is shown extending in the parallel direction, similar to FIG. 7.


Preferably, the cannula device 1 of the present invention is made from the following materials, but is not limited to the materials described herein. One of skill in the art will recognize that other materials are possible and are within the scope of the present invention.


The housing 2 of the cannula device 1 of the present invention is preferably made from a plastic material, more preferably polypropylene. The membrane of the present invention is preferably made of silicone, more preferably self-sealing silicone. The membrane is preferably adapted to be penetrated by and seal around a piercing member to enable fluid communication with the cannula of the cannula device or with at least one cavity for each of the receiving directions.


The cannula 4 of the cannula device 1, as shown, preferably is a soft cannula. Preferably, the cannula 4 is made of a plastic material. Preferred plastic materials for the soft cannula 4 are also materials which are sufficiently flexible to, bend, when the patient moves and sufficiently rigid to avoid kinking and closing off the drug supply. Further, the material should be compatible with medical use i.e. minimal skin irritation, non-toxic, non-decomposable in the body, etc. Thermoplastic elastomers (TPE) are a type of materials which satisfy these requirements. Examples of such elastomers include, but are not limited to: polyester ethers, ECDEL, styrene based TPE, olefin based TPE, urethane based TPE, ester based TPE, amid based TPE, polyolefines and silicone rubbers. In a preferred embodiment, the material is selected from the group consisting of polypropylene, C-FLEX™, mixtures of C-FLEX™, and polypropylene, LUPOLEN™ 1840H, LUPOLEN™ 3020D, PELLETHANE™ 2363-75D, PELLETHANE™ 2363-55D, TECOTHANE™ and CARBOTHANE™.


An alternative embodiment of the present invention is shown in FIGS. 13-25 illustrating the same cannula device 1 mounted in a different type of base part 200. FIGS. 13-25 show how the cannula device of FIGS. 1-12 can be mounted in different types of infusion sets, illustrating an advantage of the cannula device of the present invention.


As shown in FIG. 13, the cannula device 1 is engaged with the base part 200 in the first direction 18 where the cannula 4 is generally parallel to a main plane 218 of the base part 200. FIG. 13 also shows the inserter 50 with the needle 51 connected to the cannula device 1 and extending through the cannula 4. The projections 22 extend from the inserter 50 and slidably engage with the guiding members 5 of the cannula device 1.


In this embodiment, the base part 200 includes guiding members 201 which fit together with the guiding members 5 on the cannula device 1 as described above. The cannula 4 extends through an opening 203 in the base part 200, the opening 203 being sized to receive a annular ring 210 of the cannula device 1. The base part 200 further includes upstanding guiding members 206, 207 adapted for sliding reception of corresponding guiding members 208, 209 of a protecting member 204 once the inserter 50 is removed from the cannula device 1. The protecting member 204 may cover the cannula device 1 while the cannula 4 is secured in the skin of the patient and capable of delivering therapeutic substances to the patient through the cannula 4.


The guiding members 208, 209 can best be seen in FIG. 16 where the guiding members 206, 207 of the base 200 and the guiding members 208, 209 of the protecting member 204 are adapted to rotatably fit together to removably secure the protecting member 204 to the base part 200. Preferably, the guiding members 207, 208 may further include barbed projections 211 to facilitate the engagement. The guiding members 206, 209 may also include barbed projections 111. As shown in FIG. 13, the base part 200 preferably includes two upstanding guiding members 206, 207 on opposite sides of the base part 200. Alternatively, any number of guiding members 206, 207 or only guiding member 207 may be used to engage corresponding guiding members 208, 209 or guiding member 208 respectively, and the guiding members 206, 207 and 208, 209 may be of any size sufficient to removably secure the protecting member 204 to the base 200. other alignment, locking and/or guiding mechanism may be implemented.


The protecting member 204 may include an opening 212 as best can be seen in FIG. 15. Tubing (not shown) for delivering a therapeutic substance to the cannula device 201 may be inserted through the opening 212 so that the therapeutic substance may be delivered to the patient through the cannula 4 while the cover is in position on the base part 200. The protecting member 204 may further include elongate openings 214 on opposite sides of the protecting member 204. Preferably, the openings 214 extend from the periphery 216 of the member 204 inward and generally follow the contour of the periphery 216. Sides 218 of the protecting member adjacent the openings 214 provide partially flexible surfaces for gripping and turning the protecting member 204 to engage or release the base member 200. However, one of skill in the art will recognize that alternative engagement and release may be achieved by any mechanism commonly known to one of skill in the art.



FIG. 14 illustrates the cannula device 1 engaged with the base part 200 in the second direction 20 where the cannula 4 is generally perpendicular to the main plane 218 of the base part 200. FIG. 14 also shows the inserter 50 with the needle 51 connected to the cannula device 1 and extending through the cannula 4. The engagement of the inserter 50 and the protecting member 204 are as described above in FIG. 13. Once the inserter 50 is removed from the cannula device 1 and base part 200, the protecting member 204 may be engaged with the guiding members 206, 207 of the base part 200 as shown in FIG. 15. In some embodiments, protecting members may be engaged with the base part while an inserter is also engaged with the base part as described below. In the embodiment shown in FIG. 15, the cannula 4 extends from the bottom of the base 200. As discussed above, tubing may extend from the opening 212.



FIG. 16 illustrates a sectional view of the device shown in FIG. 15 where the protecting member 204 is engaged with the base part 200 and the cannula device 1 is positioned in the base part 200 with the cannula 4 projecting from the base part perpendicular to the main plane 218 of the base part 200. The protecting member 204 is sized and shaped to fit with the base part 200.


The guiding member 207 of the base part 200 and the guiding member 208 of the protecting member 204 having barbed projections 211 on the inner pair of guiding members 207, 208 are shown rotatably secured together. As discussed above and shown in FIG. 16, the outer pair of guiding members 207, 208 do not include barbed projections 211, however one of skill in the art will recognize that each of the guiding members 207, 208 may include guiding projections 211. The entry channels 17 and 19 of the cannula device 1 are below the membrane 3 that is protected by the protecting member 204.



FIG. 17 illustrates the same cannula device 1 engaged with the same base part 200 via the guiding members 5 of the cannula device 1 inserted into the base guiding members 201 where the cannula 4 extends in the first direction 18 generally parallel to the main plane 218 of the base part 200. FIG. 17 illustrates a pair of protecting members 250, 252 that may be engaged with the base part 200 to cover the cannula device 1 and the base part 200. The protecting members 250, 252 are sized and shaped to fit together with the base part 200 to cover the base part 200. As discussed above, alternative shapes for the base part 200 and the protecting members 250, 252 are possible. Other structures for mating these multiple members together may also be utilized.


The protecting member 250 includes a pair of guiding members 254 that may be adapted to engage the guiding members 207 of the base part 200. As described above, the base part 200 may include guiding members 206. The guiding members 206 may slide together with protrusions 256 on the periphery 258 of the protecting member 250. The protecting member 250 may further include a notch 260 for engaging an edge 270 of the base part 200. The protecting member 250 covers a portion of the membrane 3 of the cannula device 1 and may also engage the protecting member 252 to cover the base part 200 when the base part 200 is adhered to the skin of the patient and the cannula 4 is positioned transcutaneously for delivery of the therapeutic substance. As shown in FIG. 17, the protecting member may include a portion 264 for covering the membrane 3 of the cannula device 1 and the portion 264 may be made from a material that is different from the remainder of the protecting member and penetrable by a needle, such as the needle 51 of the inserter 50. For example, the portion 264 may be integrally molded to the member 250 and be formed from an elastomer. The protecting member 252 may be slidably engaged with the protecting member 250.



FIG. 18 shows the protecting member 250 engaged with the base part 200 as described above for FIG. 17. While the protecting member 250 is engaged with the base part 200, the protecting member 252 may be removed from the protecting member 250 and the base part 200. The needle 51 of the inserter 50 may be inserted into the membrane 3 of the cannula device 1 and extend through the cannula 4 in the first direction 18. The inserter 50 may be removed and replaced with the protecting member 252 or alternatively with a connector, such as a connector 450, 550, 650 described below, for delivery of a therapeutic substance.



FIG. 19 illustrates the cannula device 1 (beneath the protecting members 250, 252) engaged with the base part 200 in the second direction 20 and the inserter 50 having needle 51 inserted into the cannula device 1 through the cannula 4 in the second direction. FIG. 19 shows the needle 51 penetrating the portion 264 of the protecting member 250. When the cannula device 1 is engaged with the base part 200 in the second direction 20, the protective members 250, 252 may remain engaged with the base part 200, protecting the base part 200 and the cannula device 1 while the needle 51 of the inserter 50 extends through the cannula 4.



FIG. 20 illustrates the embodiment described above for FIG. 17 showing the protecting member 250 engaged with the base part 200 and the protecting member 252 not yet engaged. As shown, the protecting member 252 may be engaged parallel to the direction of the cannula 4 extending from the base part 200. FIG. 21 illustrates the compact size of the device when the protecting member 252 is engaged with the protecting member 250 and the base part 200. In this configuration, the more sensitive parts of the device are concealed and protected, and the assembly itself is easily transported or packaged. As described above, the protecting member 252 may be removed and a connector may be inserted in place of the protecting member 252, having a similar compact size.



FIG. 22 illustrates perspective views of the cannula device 1 and includes several assembly configuration including the base parts 100, 200 and the protecting members 104, 105, 204, 250, 252. FIG. 22A shows the cannula device 1 itself. FIG. 22B shows the cannula device 1 inserted into the base part 100. The protecting members 104, 105 cover the base part 100 and the cannula device 1 with at least part of the membrane 3 accessible for insertion of a needle of an inserter or a connector for delivery of a therapeutic substance.



FIG. 22C shows the cannula device 1 engaged with the base part 200. The protecting member 204 is shown covering the cannula device 1 and the base part 200 and has been described above.



FIG. 22D shows the cannula device 1 engaged with the base part 200 and protecting members 250, 252 covering the device 1 and base part 200.



FIGS. 23A-D illustrate side views of the cannula device 1 engaged with the corresponding different embodiments shown in FIGS. 22B-D.



FIGS. 24A-D illustrate top views of the embodiments shown in FIGS. 22B-D respectively.



FIG. 25 illustrates another embodiment of the present invention. As shown, a base part 300 is engaged with protecting members 350, 352 to form a compact device. An adhesive layer 310 for adhering the base part 300 to the patient's skin is shown connected to the base part 300.



FIG. 26 illustrates a sectional view of the embodiment shown in FIG. 25. The base part 300 includes a plurality of projections 320 having bottom surfaces 322 that together form the bottom surface 324 of the base part 300 as shown in FIGS. 26 and 28. An entry port 328 may be formed in the base part 300 wherein the entry port 328 is connected to a canal 330 that fluidly connects with a cannula 304 that extends from the base part 300. The protecting member 352 may be removed and a connector, such as the connector 450, 550, 650, described below, may be inserted at the same position for delivery of a therapeutic substance. The adhesive layer 310 adheres to the bottom surfaces 322 of the base part 300 and may be formed from a material that may be penetrated by a needle of an inserter (not shown) extending through the cannula 304. Alternatively, the adhesive layer 310 may include an opening through which the cannula 304 may extend.



FIG. 27 shows an exploded view of the embodiment shown in FIG. 25. As shown, the protecting member 352 includes guiding arms 306 and locking arms 307 for engagement of the protecting member 352 with the base part 300. The locking arms 307 may engage the base part 300 through corresponding openings 314 in the base part 200 as described above in FIGS. 5 and 6.



FIG. 28 shows an exploded bottom view of the embodiment shown in FIG. 25. The projections 320 having bottom surfaces 322 on the base part 300 are shown. The base part 300 may further include a peripheral surface 332 that extends around the periphery of the base part 300 to which the adhesive layer 310 may adhere in addition to the surfaces 322. As shown in the FIGS. 25-28, the general shape of the embodiment is cylindrical having the adhesive layer 310, the base part 300, and the protecting members 350, 352 shaped to fit together to form a compact device. One of skill in the art will recognize that alternative shapes are possible, including but not limited to oval, rectangular, and square shapes, preferably where the assembly of embodiment may form a compact device.



FIGS. 29A and 29B show an alternative embodiment of a cannula device 401. The cannula device 401 includes a housing 402, a membrane 403 and openings 405, 407. Preferably, the housing 402 may be essentially cylindrically shaped, although other shapes are possible. In the present embodiment, the cylindrical shape includes radially extending projections 413 (or flanges) that define openings 405 and 407 and may be used as guides when positioned in a base part, such as base part 400, shown in FIG. 30 A. As shown in the sectional view in FIG. 29B, the membrane 403, together with the housing 402 define a cavity 406 within the housing 402 for reception of a cannula from a connector (described below). A cannula 404 extends from the housing 402 below the cavity 406 as shown in FIG. 29B. In this embodiment, the housing 402 may be rotatably attached to the base part 400, shown in FIG. 30, so that the rotatable attachment allows the housing 402 to rotate in the base part 400 after insertion of the cannula 404 into the skin of the patient, without movement of the cannula 404 and thereby minimizing pain to the patient. Alternatively, the base part 400 may be turned to a desired angle relative to the cannula 404 and then inserting the cannula 404 using an inserter such as inserted 50 shown in FIG. 4. As shown in FIG. 29A, end portions 412 protrude from the housing 402. Preferably, the end portions 412 may be generally circularly shaped to provide for rotation within the base part 400. However, the end portions 412 may be any size and shape that is movable within the base part 400 known to one of skill in the art.


In FIGS. 30A and B, the cannula 404 of the cannula device 401 can be seen connected to the base part 400 and a connector 450. In this embodiment, the base part 400 includes connecting members 446 adapted to receive the end portions 412 of the housing 402. The connecting members 446 and the end portions 412 may be shaped and sized to facilitate rotation of the housing 402 with respect the base part 400. The device 401 further includes an adhesive layer 410 for adhering the base part 400 to the patient's skin. The adhesive layer 410 is shown connected to the base part 400 and the adhesive layer 410 may include a cutout 448 for the cannula 404 when the end portion 412 of the housing 402 is rotated in the connecting member 446 of the base part 400 to change the angle of the cannula 404 with respect to the skin.


The connector 450 connects to the cannula device housing 402 via openings 405, 407 in the housing 402. (Also shown and described below with reference to FIG. 31A.) The connector 450 may further include tubing 452 for delivering a therapeutic substance to the cannula 404 for delivery to the patient. The connector 450 may include a button 454 for release of the connector 450 from the housing 402. Alternatively, any method for releasing the connector 450 from the housing 402 may be used, including, but not limited to pressing on an exterior portion 456 on each side of the connector 450 to release gripping arms 458 (shown in FIG. 31A).



FIG. 31A illustrates the connector 450 prior to connection with the housing 402. The connector 450 may include locking arms 458 and guiding members 470 similar to the locking arms and guiding members described above for the protecting member with the cannula device 1. The locking arms 458 allow the connector 450 to be inserted into the openings 405 of the housing 402 and be removably locked in place for delivery of the therapeutic substance. The connector 450 may also include a piercing member 480 that connects the connector 450 to the cannula 404. The piercing member 480 may be inserted through the membrane 403 and into the cannula 404 or into the chamber 406 to fluidly connect with the cannula 404. The piercing member 480 may be adapted to be broken at a predetermined place. This allows the connector 450 to be used as an inserter for inserting the cannula 404 of the cannula device 401. Then the piercing member 480 may be broken at the desired spot and the connector 450 used in the traditional manner. The piercing member 480 extends through the membrane and may piece the membrane, but does not necessarily have to puncture the membrane. For example, the piercing member may be inserted through a pre-formed hole in the membrane. The term piercing member as used herein may include a cannula, including a rigid cannula or a needle, a semi-rigid cannula, or a soft cannula or any member suitable piercing the membrane.


As shown in FIGS. 31A and B, the base part 400 of this embodiment may be flexible or hinged to facilitate the rotation of the housing 402 in the base part 401. FIG. 31B illustrates the cannula 404 rotated toward the skin and the base part 400 flexing for rotation. The base part 401 may further include hinges 472 joined to the connecting members 446. The hinges 472 may be used for rotating the cannula 404 from parallel to the skin to angled toward the skin. Rotation of the housing 402 also allows the cannula 404 to be placed into the skin with an injector needle, such as the needle 51 shown with the cannula device 1. The connector 450 may be connected at any angle and the insertion device 480 can be inserted into the membrane 403 from a plurality of directions.



FIG. 32A shows the cavity 406 formed in the housing 402 and the cannula 404 extending from the cavity 406. FIG. 32B shows a portion of the housing 402 cut away from the base part 400. The connecting member 446 is shown in a circular configuration having a raised circumference 474 and a central depression 476 adapted to receive the end portion 412 of the housing 402. A portion of the base part 400 is shown extending from the connecting member 446. FIG. 32C shows the cannula 404 rotated from the direction parallel to the skin. FIG. 32D shows a top view of the cannula device 401.



FIGS. 33A-D illustrate the cannula device 401 having the cannula 404 extending in a different direction as previously shown in FIGS. 30-32. The cannula 404 is shown extending substantially orthogonally with respect to the cannula 404 shown in FIGS. 31-32. FIG. 33B shows the cannula device 401 with the cannula 404 extending vertically from the base part 400. The connector 450 is shown removably connected to the housing 402 in the openings 405, 407 of the housing 402. An opening 482 in the adhesive layer 410 is shown in FIG. 33B for the cannula 404 to extend through and into the skin of the patient. FIGS. 33C and D show top views of the cannula device 401 shown in FIGS. 33A and B, respectively.



FIG. 34A illustrates the housing 402 having openings 405, 407. The membrane 403 is shown in the center of the housing 402 for reception of an insertion device for fluidly delivering a therapeutic substance through the cannula 404. The end portion 412 is shown having a generally rectangular shape for mating with a similarly shaped connecting member 446 of the base part 400 shown in FIG. 34B. The housing 402 is rotatable in the base part 400 as described above.



FIG. 35 shows the cavity 406 formed inside the housing 402. The membrane 403 may cover a portion of the cavity 406. A top portion 484 of the cannula 404 connects with the cavity 406 in the housing 402. The cavity 406 allows for an piercing member of a connector to be inserted into the membrane 403 in any reception direction and have the cannula 404 be in fluid communication with the connector for delivery of the therapeutic substance. In this embodiment, the cannula 404 is shown extending vertically from the housing 402 in relation to the plane 418 of the base part 400. A pair of openings 486 is shown on the housing 402 for reception of a connector or a protective member in two different directions. The base part 400 also includes the connecting member 446 in a generally square shape for reception of the end portion 412 of the housing 402. The adhesive layer 410 may be adhered to the skin of the patient.



FIGS. 36A-E show the cannula device 401 from different angles. FIG. 36A shows a top view of the cannula device 401 with the connector 450 connected to the housing 402. The cannula 404 is shown extending in a direction generally parallel to the base part 400. Tubing 452 extends from the connector 450 for connection to a medical device (not shown) for delivery of a therapeutic substance. FIG. 36B shows the cannula device 401 from FIG. 36A with the connector 450 removed. FIG. 36C shows a perspective view of the cannula device 401 of FIG. 36A. FIG. 36D shows a rear perspective view of the cannula device 401 and FIG. 36E shows a rear perspective view of the cannula device 401 with the connector 450 connected to the housing 402.



FIGS. 37A-C illustrate the cannula device 401 with the cannula 404 extending in a direction generally vertically to the plane 418 of the base part 400. FIG. 37A shows the connector 450 connected in one set of the openings 484 in the housing 402 wherein the connection is parallel to the plane of the base part 400. The second set of the pair of openings 488 are shown opening in a second direction that the connector 450 may be inserted into wherein the connection is generally orthogonal to the plane 418 of the base part 400. FIG. 37B shows a side perspective view of the cannula device 401 and the cannula 404 extending below the base part 400. FIG. 37C shows a top view of the device shown in FIG. 37A.



FIG. 38A shows the cannula device of FIG. 37A with the housing 402 repositioned in the base part 400 so that the cannula 404 extends generally parallel main plane 418 of the base part 400. The connector 450 is shown connected to the housing 402 in a parallel direction to the plane 418 of the base part 400. FIG. 38B is a top view of the cannula device 401 shown in FIG. 38A where the guiding arms 470 and the locking arms 458 from the connector 450 can be seen connected to the housing 402 for removable connection.



FIG. 39 illustrates a cannula device 501 connected to an inserter 550. The cannula device 501 is shown removed from a base part to show the connection of the inserter 560 with the guiding members 505 of the cannula device 501.


As shown in FIGS. 40A and B, the cannula device 501 may be connected to a connector 550 at different heights and distances from skin of the patient so that the cannula 504 may extend into the skin of the patient in varying depths. A positioning member 507 is shown in FIGS. 40A and 41A positioned beneath the cannula device 501. The positioning member 507 may be positioned between a base member 500 (shown in FIG. 43) and the cannula device 501 for changing the height and distance that the cannula 501 may be inserted into the skin. The positioning member 507 allows the cannula device 501 to be positioned higher in the connector 550 in FIG. 40A when compared to the position of the cannula device in the connector 550 in FIG. 40B without a positioning member (see also FIGS. 41A and 41B). The cannula device may also be positioned at multiple heights with respect to the base part using multiple guiding members. Multiple positions of the cannula device with respect to the base part allow one cannula device and one base part together to be used for more than one insertion depth, adapting the infusion set to the individual patient and also so that the infusion set may also be used for both children and adults. The cannula device 501 also includes a membrane 503 that is adapted to receive a piercing member 580, such as a cannula, from the connector 550 to fluidly connect the connector 550 to the cannula 504 for delivery of a therapeutic substance. As will be understood by one of skill in the art, the cannula may be rigid, for example, but not limited to, a needle, semi-rigid, or soft.



FIGS. 41A and B show a partial view of the embodiments shown in FIGS. 40A and B, respectively. FIG. 41A illustrates an embodiment that allows the connection of the cannula device 501 with the connector 550 from two different directions. As shown, the membrane 501 is a single membrane mounted to the housing 502. As described blow, multiple members 503 are possible. The piercing member 580, shown as a cannula, may extend from the connector 550 and penetrate the membrane 503 and depending on the direction from which the piercing member 580 is received in the cannula device 501, the piercing member 580 may end in one of two cavities 512 formed in the cannula device 501. The two cavities 512 may be in fluid communication with each other via a canal 514 formed in the cannula device 501. Preferably the canal 514 is provided in the interior of the housing 502. This embodiment allows the piercing member 580 to be in fluid communication with the cannula 504 regardless of the direction from which the insertion device is inserted through the membrane 503. As shown in FIG. 41A, the piercing member 580 may be essentially orthogonal with the cannula 504 of the cannula device 501 and the cavity 512, in to which the piercing member 580 inserts and ends, fluidly connects the canal 514 and a cavity 516 connected to the cannula 504. One of skill in the art will recognize that the piercing member 580 may also be inserted into the membrane 503 from a direction essentially parallel to the cannula 504 from the top of the cannula device 501. The piercing member 580 may also be inserted through the membrane 503 and the piercing member 580 may end in the cannula 504 and thus the piercing member 580 may fluidly connect directly with the cannula 504 without connecting via a cavity 512 or a canal 514.



FIG. 41B illustrates the cannula device 501 that may be connected to the piercing member 580 from two directions and in which the piercing member 580 connects to the single cavity 522 from either direction through the membrane 503. When the piercing member 580 is inserted through the membrane 503 in the orthogonal direction to the direction of the cannula 504, the insertion device may enter the cavity 522 from a hole 524 in a wall 523 of the cavity 522. FIGS. 41A and B also illustrate the cannula device 501 connected at different heights in the connector 550.



FIGS. 42A and B illustrate side views of the cannula device 501 connected to the cannula device 501 at different heights in the connector 550.



FIG. 43 illustrates the connector 550 connected to the cannula device 501 and the cannula device 501 may be mounted in a base part 500. As shown, the connector 550 is connected in a direction parallel to the main plane of the base part 500. The connector 550 includes the piercing member 580 that is shown connecting through the membrane 503 directly with the cannula 504.



FIG. 44 shows the cannula device 501 connected to the connector 550 and mounted in the base part 500. The cannula 504 extends in the direction parallel to the plane 518 of the base part 500, orthogonal to the direction shown in FIGS. 42A and B. The connector 550 includes guiding arms 506 and locking arms 507. As described above, the guiding arms help to position the cannula device 501 in the base part 500 and the locking arms 507 removably lock the connector 550 with the base part 500. The locking arms 507 are shown extending into and locking with a portion of the base part 500 and into an opening 511 on the base part 500. Side portions 513 of the locking arms 507 may include ridges 517 to help the patient grip the locking arms 507 and slidably push together the connector 550 and the base part 500 to removably lock the connector 550 with the base part 500. The gripping arms 507 may also be flexible so that the patient may press inwardly on the locking arms 507 to release the locking arms from the base part 500. A portion of the membrane 503 remains exposed at the top of the cannula device 501.



FIG. 45 shows the cannula device 501 together with the connector 550 and tubing 552 and the base part 500. An adhesive layer 510 is also shown having a cutout portion 515 for the cannula 504.



FIG. 46 illustrates the cannula device 501 mounted on the base part 500 with the cannula 504 extending in the direction parallel to the main plane of the base part 500. An inserter 560 may be connected to the base part 500 and the cannula device 501. A needle 561 extends from the inserter 560 though the membrane 503 of the cannula device and through the cannula 504. FIG. 47 illustrates the cannula device 501 shown in FIG. 46 may be rotated orthogonally to the direction shown in FIG. 46 and mounted to the same base part 500 shown in FIG. 46. The cannula 504 extends downward from the base part 500. The inserter 560 is also shown connected to the base part 500 and the cannula 501 in the direction orthogonal to that shown in FIG. 46.



FIG. 48 shows the inserter 560. The needle 561 extends from the inserter 560 and guiding arms 563 may extend on both sides of the needle 561 for slidable connection with the guiding members of the cannula device (described and shown above) to guide the inserter 560 into position in the cannula device 501.



FIG. 49 shows an embodiment similar to the embodiment shown in FIG. 45 having an angled base part 600. The angled base part 600 can best be seen in the side view shown in FIG. 51, wherein the connector 650 is shown inserted in the base part 600 at an angle to the main plan of the base part 618. A cannula device 601 may be mounted in the base part 600 in several directions including as shown in FIG. 49 having a cannula 604 extending from the base part 600 in a direction generally parallel to the plane 618 of the base part 600. A connector 650 may be connected to the base part 600 and the cannula device 601. The connector 650 may include an piercing member 680 that inserts through the membrane 603 of the cannula device 601 for fluid connection between tubing 652 to the cannula 604 for delivery of a therapeutic substance to the skin of a patient. The connector 650 may also include locking arms 607 extending though an opening 611 in the connector 650 for removably locking the connector 650 to the base part 600. An adhesive layer 610 is also shown connected to the base part 600 and the adhesive layer 610 may include a cut out portion 615 for the cannula 604. FIG. 50 shows a top view of the embodiment shown in FIG. 49.



FIG. 52 shows the cannula device 601 having an angled base part 600. As described above, the connector 650 may be connected with the base part 600. The connector 650 further includes guiding arms to help position the cannula device 601 in the base part 600 (not shown, described above for example in FIG. 6). Locking arms 607 removably engage the base part 600 though the opening 611 in the base part 600. The locking arms 607 are shown extending into and removably locking with a portion of the base part 600 into the opening 611 on the base part 600. Side portions 613 of the locking arms 607 may include ridges 617 to help the patient grip the locking arms and removably lock the connector 650 with the base part 600. The gripping arms 607 may also be flexible so that the patient may press inwardly on the locking arms 607 to release the locking arms 607 from the base part 600. FIGS. 53-57 illustrate perspective views of the cannula device 601 shown in FIG. 52.



FIGS. 58-65 illustrate another preferred embodiment of the present invention. In FIGS. 58 and 59, a cannula device 701 is cubically shaped and is positioned in a base part 700 so that a cannula 704 of the cannula device 701 is essentially orthogonal to a main surface 705 of the base part 700. As described above, other shapes for the cannula device 701 are possible. The cannula device 701 can receive both an inserter needle of an inserter (as described above and shown, for example, in FIG. 4) and a connector 750 having a cannula 751 from a direction being essentially parallel with the cannula 704. The cannula device 701 includes at least one membrane 703 through which the inserter needle or the piercing member 751 inserts. FIGS. 58 and 59 illustrate the cannula device 701 having two membranes 703, although one of skill in the art will understand that more membranes 703 are possible. A protective member or inserter may also be used with the cannula device 701 and base part 700 in place of the connector 750 as described above.


Further FIGS. 58 and 59 show that it is possible for the connector 750 to connect with the base part 700 from a direction being essentially orthogonal to the direction of the cannula 704 and the piercing member 751 can pierce the membrane 703 from a direction orthogonal to the direction of the connector 750 shown in FIG. 58. The cannula device 701 is constructed in such a manner that the cannula 704 is in fluid communication with the piercing member 751 when received regardless of the direction from which the piercing member 751 is received. In the embodiment shown in FIGS. 58 and 59, the cannula device includes a cavity 706 similar to the cavity 6 described above for the cannula device 1. Alternatively, the cannula device 701 may not include a cavity 706 wherein the piercing member 751 fluidly connects with the cannula 704, similar to the reception of the piercing member without having a cavity 706, similar to the device described above in FIG. 41B.



FIGS. 58 and 59 also illustrate an alternative mechanism for removable locking the connector 750 with the base part 700. The connector 750 includes locking arms 707 for removably locking the base part 700 to the connector 750. The locking arms 707 further include notched projections 720 for engaging angled projections 722 on the base part 700. The notched projections 720 of the connector 750 slidably engage the angled projections 722 of the base part 700. The projections 720 snap together with the projections 722 and the projections 720 fit into a gap in the base part 700 to releasably lock the base part 700 to the connector 750. The base part 700 may be released from the connector 750 by pressing on the projections 720. The connector 750 may also include guiding arms 706 to slidably engage guiding members 705 of the cannula device 701. Of course, alternative locking means may be used to releasably engage the base part 700 with the connector 751.



FIGS. 58-60 illustrate the cannula 704 extending essentially perpendicular to the main surface 705 of the base part 700 so that the cannula 704 penetrates the patient's skin essentially perpendicular to the main surface 705 of the base part 700. The base part 700 includes an opening 709 through which the cannula 704 of the cannula device 701 may extend.



FIG. 61 illustrates the cannula 704 extending essentially parallel to the main surface 705 of the base part 700 through the opening 709 in the base part 700. FIGS. 62 and 63 illustrate the cannula device 701 prior to connection with the base part 700 where the cannula 704 will extend through the opening 709 essentially parallel to the main surface 705 of the base part 700.



FIG. 64 shows an example of an interior portion 713 of the cannula device 701. In this embodiment, the piercing member 751 will insert directly into a channel 715 without having a cavity for fluidly connecting the piercing member 751 with the cannula 704 as described above. The cannula connector 751 can pierce the membranes 703 from either direction shown and directly enter the channels 715 to fluidly connect with the cannula 704.


Although the invention herein has been described in connection with a preferred embodiment thereof, it will be appreciated by those skilled in the art that additions, modifications, substitutions, and deletions not specifically described may be made without departing from the spirit and scope of the invention as defined in the appended claims. It is therefore intended that the foregoing detailed description be regarded as illustrative rather than limiting, and that it be understood that it is the following claims, including all equivalents, that are intended to define the spirit and scope of this invention.

Claims
  • 1. A cannula device for mounting to a base part of an infusion set, said device comprising: a housing and at least one membrane adapted to receive a piercing member; anda cannula mounted to said housing; wherein said cannula device is adapted to removable attach to said base part in a first attachment configuration or a second attachment configuration and wherein said cannula device can receive said piercing member of a connector from a first receiving direction in the first attachment configuration and from a second receiving direction in the second attachment configuration, the second receiving direction being different from said first direction providing fluid communication between said piercing member and said cannula.
  • 2. The cannula device according to claim 1 wherein said at least one membrane further comprises a first membrane oriented generally perpendicular to said first receiving direction and a second membrane oriented generally perpendicular to said second receiving direction.
  • 3. The cannula device according to claim 1 wherein said at least one membrane further comprises a single membrane oriented to intersect both said first and second receiving directions.
  • 4. The cannula device according to claim 1 wherein an angle between the first and the second receiving directions is at least 45°.
  • 5. The cannula device according to claim 4 wherein said angle is at least 60°.
  • 6. The cannula device of claim 4 wherein said angle is at least 75°.
  • 7. The cannula device of claim 4 wherein said angle is at least 85°.
  • 8. The cannula device according to claim 1 wherein the cannula device is adapted to receive the piercing member from a third direction.
  • 9. The cannula device according to claim 8 wherein an angle between said first direction and said third direction is between about 5° and about 175°.
  • 10. The cannula device of claim 8 wherein an angle between said first direction and said third direction angle is between about 30° and about 150°.
  • 11. The cannula device according to claim 1 wherein said at least one membrane is self-sealing.
  • 12. The cannula device according to claim 11, wherein said at least one membrane is made of silicone.
  • 13. The cannula device according to claim 1, wherein said housing defines a plurality of cavities.
  • 14. The cannula device according to claim 1 wherein said cannula device has a generally cylindrical shape.
  • 15. The cannula device according to claim 1 wherein said housing and said at least one membrane together define at least one cavity.
  • 16. The cannula device according to claim 1 wherein said cannula device can be attached to said base part at different levels with respect to said base part.
  • 17. The cannula device according to claim 1 wherein said base part comprises attachment members adapted for removable attaching said cannula device to said base part in more than one direction with respect to said base part.
  • 18. The cannula device according to claim 1 comprises guiding members adapted to engage with guiding members of said cannula device for positioning said cannula device on said base part.
  • 19. The cannula device according to claim 18, wherein the guiding members guide both the assembling of the cannula device with a base part and coupling to the base part one of a connector and an inserter.
  • 20. The cannula device according to claim 1 further comprising locking members.
  • 21. The cannula device according to claim 20 wherein said locking members removable connect said cannula device to said base part.
  • 22. The cannula device according to claim 1 wherein said locking members removable connect a connector to said base part.
  • 23. The cannula device according to claim 1 wherein said cannula device is selectively rotatable relative to said base part.
  • 24. The cannula device according to claim 23 further comprising hinges for attaching said cannula device to said base part.
  • 25. A cannula device for mounting to a base part of an infusion set, said device comprising: a housing and at least one membrane adapted to receive a piercing member of a connector; anda cannula mounted to said housing;wherein said housing is adapted to be repositionable relative to said base part in more than one orientation with respect to said base part.
  • 26. The cannula device of claim 25 wherein said housing further comprises guiding members for position said device on said base part.
  • 27. The cannula device of claim 26 wherein said housing is repositionable at different levels with respect to said base part for changing the distance said cannula is inserted into the skin of a patient.
  • 28. The cannula device of claim 26 wherein said housing is repositionable within said housing in at least a first direction and a second direction wherein an angle between said first direction and said second direction is at least 45°.
Parent Case Info

This application claims the benefit of U.S. Provisional Application No. 60/600,209, filed Aug. 10, 2004.

US Referenced Citations (598)
Number Name Date Kind
643544 Simmons Feb 1900 A
1592462 MacGregor Jul 1926 A
1838825 Goldstein Jan 1929 A
1991103 King Feb 1935 A
2047010 Dickinson Jul 1936 A
2295849 Kayden Sep 1942 A
2319731 Garrett May 1943 A
2533731 Gomberg Dec 1950 A
2630803 Baran Mar 1953 A
2690529 Lindblad Sep 1954 A
2730099 Sullivan Jan 1956 A
2839060 Ormo Jun 1958 A
2936141 Rapata May 1960 A
2952420 Von Hoorn Sep 1960 A
2972779 Cowley Feb 1961 A
3055361 Ballard Sep 1962 A
3059802 Mitchell Oct 1962 A
3074541 Roehr Jan 1963 A
3107785 Roehr Oct 1963 A
3154080 Rowan et al. Oct 1964 A
3221739 Rosenthal Dec 1965 A
3221740 Rosenthal Dec 1965 A
3306291 Burke Feb 1967 A
3317166 Janssen May 1967 A
3485352 Pilger Dec 1969 A
3509879 Bathish et al. May 1970 A
3519158 Anderson Jul 1970 A
3545286 Stenstrom Dec 1970 A
3547119 Hall et al. Dec 1970 A
3610240 Harautuneian Oct 1971 A
3648999 Bauer Mar 1972 A
3670727 Reiterman Jun 1972 A
3783895 Weichselbaum Jan 1974 A
3783996 Gerard et al. Jan 1974 A
3788374 Saijo Jan 1974 A
3810469 Hurschman May 1974 A
3814097 Ganderton et al. Jun 1974 A
3831729 Howard Aug 1974 A
3840011 Wright Oct 1974 A
3865236 Rycroft Feb 1975 A
3893448 Brantigan Jul 1975 A
3937219 Karakashian Feb 1976 A
3942528 Loeser Mar 1976 A
3986507 Watt Oct 1976 A
3986508 Barrington Oct 1976 A
3995518 Spiroff Dec 1976 A
4014328 Cluff et al. Mar 1977 A
4022205 Tenczar May 1977 A
4146113 Gavel Mar 1979 A
4150798 Aragon Apr 1979 A
4188950 Wardlaw Feb 1980 A
4201406 Dennehey et al. May 1980 A
4227528 Wardlaw Oct 1980 A
4259276 Rawlings Mar 1981 A
4267836 Whitney et al. May 1981 A
4296786 Brignola Oct 1981 A
4306705 Svensson Dec 1981 A
4315505 Crandall et al. Feb 1982 A
4333455 Bodicky Jun 1982 A
4334551 Pfister Jun 1982 A
D267199 Koenig Dec 1982 S
4365630 McFarlane Dec 1982 A
4378015 Wardlaw Mar 1983 A
4400861 Parker Aug 1983 A
4406042 McPhee Sep 1983 A
4415393 Grimes Nov 1983 A
4417886 Frankhouser et al. Nov 1983 A
4458344 Coogler Jul 1984 A
4464178 Dalton Aug 1984 A
4472024 Konomura et al. Sep 1984 A
4473369 Lueders et al. Sep 1984 A
4484910 Sarnoff et al. Nov 1984 A
4500312 McFarlane Feb 1985 A
4517971 Sorbonned May 1985 A
4525157 Vaillancourt Jun 1985 A
4530695 Phillips et al. Jul 1985 A
4531686 Shaw Jul 1985 A
4531937 Yates Jul 1985 A
4563177 Kamen Jan 1986 A
4576846 Noel Mar 1986 A
4606735 Wilder et al. Aug 1986 A
4610469 Wolff-Mooij Sep 1986 A
4616790 Beltran Oct 1986 A
4617019 Fecht Oct 1986 A
4619349 Braun Oct 1986 A
4635683 Nielsen Jan 1987 A
4637404 Gessman Jan 1987 A
4662873 Lash et al. May 1987 A
4682702 Gach Jul 1987 A
4713059 Bickelhaupt et al. Dec 1987 A
4734092 Millerd Mar 1988 A
4755173 Konopka et al. Jul 1988 A
4758020 Boyd Jul 1988 A
4800629 Ikeda Jan 1989 A
4802638 Burger et al. Feb 1989 A
4817603 Turner et al. Apr 1989 A
RE32922 Levin et al. May 1989 E
4838871 Luther Jun 1989 A
4840613 Balbierz Jun 1989 A
4850974 Bickelhaupt et al. Jul 1989 A
4850996 Cree Jul 1989 A
4863016 Fong et al. Sep 1989 A
4878897 Katzin Nov 1989 A
4890608 Steer Jan 1990 A
4894054 Miskinyar Jan 1990 A
4895570 Larkin Jan 1990 A
D306500 Brahler Mar 1990 S
4913369 Lia et al. Apr 1990 A
4917669 Bonaldo Apr 1990 A
4935010 Cox et al. Jun 1990 A
4950163 Zimble Aug 1990 A
4950252 Luther et al. Aug 1990 A
4978338 Melsky et al. Dec 1990 A
4982842 Hollister Jan 1991 A
4986817 Code Jan 1991 A
4994042 Vadher Feb 1991 A
4994045 Ranford Feb 1991 A
5011475 Olson Apr 1991 A
5020665 Bruno Jun 1991 A
5024662 Menes et al. Jun 1991 A
5067496 Eisele Nov 1991 A
5077872 Guthammar Jan 1992 A
5083757 Barsky Jan 1992 A
5092853 Couvertier, II Mar 1992 A
5098389 Cappucci Mar 1992 A
5112313 Sallee May 1992 A
5116319 Van den Haak May 1992 A
5116324 Brierley et al. May 1992 A
5116325 Paterson May 1992 A
5121751 Panalletta Jun 1992 A
5129884 Dysarz Jul 1992 A
5134593 Logan et al. Jul 1992 A
5134594 Woo Jul 1992 A
5135502 Koenig, Jr. et al. Aug 1992 A
5137516 Rand et al. Aug 1992 A
5137524 Lynn et al. Aug 1992 A
5141496 Dalto et al. Aug 1992 A
5147319 Ishikawa et al. Sep 1992 A
5147375 Sullivan et al. Sep 1992 A
5161681 Kemp et al. Nov 1992 A
5163915 Holleron Nov 1992 A
5172808 Bruno Dec 1992 A
5176643 Kramer et al. Jan 1993 A
5176650 Haining Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5186712 Kelso et al. Feb 1993 A
5188314 Peters Feb 1993 A
5188611 Orgain Feb 1993 A
RE34223 Bonaldo Apr 1993 E
5205820 Kriesel Apr 1993 A
5222947 D'Amico Jun 1993 A
5232454 Hollister Aug 1993 A
5236143 Dragon Aug 1993 A
5240199 Peters Aug 1993 A
5248301 Koenig et al. Sep 1993 A
5256149 Banik et al. Oct 1993 A
5256152 Marks Oct 1993 A
5257980 Van Antwerp et al. Nov 1993 A
5265822 Shober, Jr. et al. Nov 1993 A
5267963 Bachynsky Dec 1993 A
5269799 Daniel Dec 1993 A
5271744 Kramer et al. Dec 1993 A
5279579 D'Amico Jan 1994 A
5279591 Simon Jan 1994 A
5282793 Larson Feb 1994 A
5300030 Crossman et al. Apr 1994 A
5312359 Wallace May 1994 A
5312369 Arcusin et al. May 1994 A
5316246 Scott et al. May 1994 A
5324302 Crouse Jun 1994 A
5342319 Watson et al. Aug 1994 A
5342324 Tucker Aug 1994 A
5343637 Schindler Sep 1994 A
5350392 Purcell et al. Sep 1994 A
5354280 Haber et al. Oct 1994 A
5366469 Steg et al. Nov 1994 A
5372592 Gambale Dec 1994 A
5372787 Ritter Dec 1994 A
5376082 Phelps Dec 1994 A
5379895 Foslien Jan 1995 A
5380067 Turvill et al. Jan 1995 A
5384174 Ward et al. Jan 1995 A
5387197 Smith et al. Feb 1995 A
5388931 Carlson Feb 1995 A
5390669 Stuart et al. Feb 1995 A
5391151 Wilmot Feb 1995 A
5403288 Stanners Apr 1995 A
5405332 Opalek Apr 1995 A
5429607 McPhee Jul 1995 A
5429613 D'Amico Jul 1995 A
5433307 Jeppe Jul 1995 A
5439473 Jorgensen Aug 1995 A
D362718 Deily et al. Sep 1995 S
5449349 Sallee et al. Sep 1995 A
5451210 Kramer et al. Sep 1995 A
5487506 Drummond et al. Jan 1996 A
5490841 Landis Feb 1996 A
5492313 Pan et al. Feb 1996 A
5501675 Erskine Mar 1996 A
5505709 Funderburk et al. Apr 1996 A
5507730 Haber et al. Apr 1996 A
5514117 Lynn May 1996 A
5519167 Kunimoto et al. May 1996 A
5520654 Wahlberg May 1996 A
5522803 Teissen-Simony Jun 1996 A
5527287 Miskinyar et al. Jun 1996 A
5533974 Gaba Jul 1996 A
5540709 Ramel Jul 1996 A
5545143 Fischell Aug 1996 A
5545152 Funderburk et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5554130 McDonald et al. Sep 1996 A
5558650 McPhee Sep 1996 A
5562629 Haughton et al. Oct 1996 A
5562636 Utterberg Oct 1996 A
5573510 Isaacson Nov 1996 A
5575777 Cover et al. Nov 1996 A
5584813 Livingston et al. Dec 1996 A
5586553 Halili Dec 1996 A
5591188 Waisman Jan 1997 A
5599309 Marshall et al. Feb 1997 A
5599315 McPhee Feb 1997 A
5599318 Sweeney et al. Feb 1997 A
5628765 Morita May 1997 A
5643214 Marshall Jul 1997 A
5643216 White Jul 1997 A
5643220 Cosme Jul 1997 A
5662617 Odell et al. Sep 1997 A
5665071 Wyrick Sep 1997 A
5665075 Gyure et al. Sep 1997 A
5676156 Yoon Oct 1997 A
5681323 Arick Oct 1997 A
5695476 Harris Dec 1997 A
5697907 Gaba Dec 1997 A
5700250 Erskine Dec 1997 A
5702371 Bierman Dec 1997 A
5704920 Gyure Jan 1998 A
5709516 Peterson et al. Jan 1998 A
5714225 Hansen et al. Feb 1998 A
5738641 Watson et al. Apr 1998 A
5741288 Rife Apr 1998 A
5752923 Terwilliger May 1998 A
5807316 Teeple Sep 1998 A
5807348 Zinger et al. Sep 1998 A
5810835 Ryan et al. Sep 1998 A
5817058 Shaw Oct 1998 A
5820598 Gazza et al. Oct 1998 A
5827236 Takahashi Oct 1998 A
5833666 Davis et al. Nov 1998 A
D402538 Wagter et al. Dec 1998 S
5843001 Goldenberg Dec 1998 A
5848990 Cirelli et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5865806 Howell Feb 1999 A
5873540 Hardin Feb 1999 A
5899886 Cosme May 1999 A
5911705 Howell Jun 1999 A
5913846 Szabo Jun 1999 A
5915640 Wagter et al. Jun 1999 A
5916199 Miles Jun 1999 A
5919167 Mulhauser et al. Jul 1999 A
5919170 Woessner Jul 1999 A
5925032 Clements Jul 1999 A
5947931 Bierman Sep 1999 A
5947935 Rinehart et al. Sep 1999 A
5951523 Osterlind et al. Sep 1999 A
5954643 VanAntwerp et al. Sep 1999 A
5957892 Thorne Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5975120 Novosel Nov 1999 A
5980488 Thorne Nov 1999 A
5980506 Mathiasen Nov 1999 A
5984224 Yang Nov 1999 A
5984897 Petersen et al. Nov 1999 A
5992787 Burke Nov 1999 A
D417733 Howell et al. Dec 1999 S
6017328 Fischell et al. Jan 2000 A
6017598 Kreischer et al. Jan 2000 A
D421119 Musgrave et al. Feb 2000 S
6024727 Thorne et al. Feb 2000 A
6039629 Mitchell Mar 2000 A
6042570 Bell et al. Mar 2000 A
6045533 Kriesel et al. Apr 2000 A
6045534 Jacobsen et al. Apr 2000 A
6050976 Thorne et al. Apr 2000 A
6053893 Bucher Apr 2000 A
6053930 Ruppert Apr 2000 A
6056718 Funderburk et al. May 2000 A
6056726 Isaacson May 2000 A
6074369 Sage et al. Jun 2000 A
6074371 Fischell Jun 2000 A
6077244 Botich et al. Jun 2000 A
6079432 Paradis Jun 2000 A
6086008 Gray et al. Jul 2000 A
6086575 Mejslov Jul 2000 A
6090068 Chanut Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6093179 O'Hara et al. Jul 2000 A
6099503 Stradella Aug 2000 A
6105218 Reekie Aug 2000 A
6106498 Friedli et al. Aug 2000 A
6120482 Szabo Sep 2000 A
6123690 Mejslov Sep 2000 A
6132755 Eicher et al. Oct 2000 A
6139534 Niedospial, Jr. Oct 2000 A
6159181 Crossman et al. Dec 2000 A
6183464 Sharp et al. Feb 2001 B1
6191338 Haller Feb 2001 B1
6193694 Bell et al. Feb 2001 B1
6210420 Mauze et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6221058 Kao et al. Apr 2001 B1
6248093 Moberg Jun 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302866 Marggi Oct 2001 B1
6319232 Kashmer Nov 2001 B1
6322535 Hitchins et al. Nov 2001 B1
6322808 Trautman et al. Nov 2001 B1
6334856 Allen et al. Jan 2002 B1
6355021 Nielsen et al. Mar 2002 B1
6379335 Rigon et al. Apr 2002 B1
D456692 Epstein May 2002 S
6387076 Landuyt May 2002 B1
6387078 Gillespie, III May 2002 B1
6405876 Seshimoto et al. Jun 2002 B1
6440096 Lastovich et al. Aug 2002 B1
6447482 Rønborg et al. Sep 2002 B1
6450992 Cassidy, Jr. Sep 2002 B1
6485461 Mason et al. Nov 2002 B1
6488663 Steg Dec 2002 B1
6503222 Lo Jan 2003 B2
6517517 Farrugia et al. Feb 2003 B1
6520938 Funderburk et al. Feb 2003 B1
D472316 Douglas et al. Mar 2003 S
D472630 Douglas et al. Apr 2003 S
6572586 Wojcik Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6582397 Alesi et al. Jun 2003 B2
6595962 Perthu Jul 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6607511 Halseth et al. Aug 2003 B2
6613064 Rutynowski et al. Sep 2003 B2
6620133 Steck Sep 2003 B1
6620136 Pressly, Sr. et al. Sep 2003 B1
6620140 Metzger Sep 2003 B1
6629949 Douglas Oct 2003 B1
6645181 Lavi et al. Nov 2003 B1
6645182 Szabo Nov 2003 B1
6659982 Douglas et al. Dec 2003 B2
6685674 Douglas et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6702779 Connelly et al. Mar 2004 B2
6726649 Swenson et al. Apr 2004 B2
6736797 Larsen et al. May 2004 B1
6749587 Flaherty Jun 2004 B2
6749589 Douglas et al. Jun 2004 B1
6755805 Reid Jun 2004 B1
6776775 Mohammad Aug 2004 B1
6790199 Gianakos Sep 2004 B1
6805686 Fathallah et al. Oct 2004 B1
6808506 Lastovich et al. Oct 2004 B2
6811545 Vaillancourt Nov 2004 B2
6814720 Olsen et al. Nov 2004 B2
6824530 Wagner et al. Nov 2004 B2
6824531 Zecha, Jr. et al. Nov 2004 B1
6830562 Mogensen et al. Dec 2004 B2
6837877 Zurcher Jan 2005 B2
6837878 Smutney et al. Jan 2005 B2
6840922 Nielsen et al. Jan 2005 B2
6880701 Bergeron et al. Apr 2005 B2
6916017 Noe Jul 2005 B2
6923791 Douglas Aug 2005 B2
6926694 Marano-Ford et al. Aug 2005 B2
6939331 Ohshima Sep 2005 B2
6949084 Marggi et al. Sep 2005 B2
6959812 Reif et al. Nov 2005 B2
6960193 Rosenberg Nov 2005 B2
6979316 Rubin et al. Dec 2005 B1
6991619 Marano-Ford et al. Jan 2006 B2
6991620 Marano-Ford et al. Jan 2006 B2
6994213 Giard et al. Feb 2006 B2
6997907 Safabash et al. Feb 2006 B2
7014625 Bengtsson Mar 2006 B2
7018344 Bressler et al. Mar 2006 B2
7022108 Marano-Ford et al. Apr 2006 B2
7047070 Wilkenson et al. May 2006 B2
7052483 Wojcik May 2006 B2
7055713 Rea et al. Jun 2006 B2
7056302 Douglas Jun 2006 B2
7070580 Nielsen Jul 2006 B2
7074208 Pajunk et al. Jul 2006 B2
D526409 Nielsen et al. Aug 2006 S
7083592 Lastovich et al. Aug 2006 B2
7083597 Lynch et al. Aug 2006 B2
7097631 Trautman et al. Aug 2006 B2
7109878 Mann et al. Sep 2006 B2
7115108 Wilkenson et al. Oct 2006 B2
7115112 Mogensen et al. Oct 2006 B2
7141023 Diermann et al. Nov 2006 B2
7147623 Mathiasen Dec 2006 B2
7186236 Gibson et al. Mar 2007 B2
7211068 Douglas May 2007 B2
7214207 Lynch et al. May 2007 B2
7214215 Heinzerling et al. May 2007 B2
7250037 Shermer et al. Jul 2007 B2
7258680 Mogensen et al. Aug 2007 B2
D554253 Kornerup Oct 2007 S
7303543 Maule et al. Dec 2007 B1
7309326 Fangrow, Jr. Dec 2007 B2
7407491 Fangrow, Jr. Aug 2008 B2
7407493 Cane′ Aug 2008 B2
7431876 Mejlhede et al. Oct 2008 B2
7569262 Szabo et al. Aug 2009 B2
7648494 Kornerup et al. Jan 2010 B2
7766867 Lynch et al. Aug 2010 B2
20010004970 Hollister et al. Jun 2001 A1
20010016714 Bell et al. Aug 2001 A1
20010021827 Ferguson et al. Sep 2001 A1
20010039387 Rutynowski et al. Nov 2001 A1
20010039401 Ferguson et al. Nov 2001 A1
20010041875 Higuchi et al. Nov 2001 A1
20010049496 Kirchhofer Dec 2001 A1
20010053889 Marggi Dec 2001 A1
20010056284 Purcell et al. Dec 2001 A1
20020022798 Connelly Feb 2002 A1
20020022855 Bobroff et al. Feb 2002 A1
20020026152 Bierman Feb 2002 A1
20020055711 Lavi et al. May 2002 A1
20020068904 Pluth et al. Jun 2002 A1
20020072720 Hague et al. Jun 2002 A1
20020074345 Scheider et al. Jun 2002 A1
20020077599 Wojcik Jun 2002 A1
20020082543 Park et al. Jun 2002 A1
20020107489 Lee Aug 2002 A1
20020111581 Sasso Aug 2002 A1
20020145073 Swanson Oct 2002 A1
20020156424 Suzuki et al. Oct 2002 A1
20020156427 Suzuki et al. Oct 2002 A1
20020161322 Utterberg et al. Oct 2002 A1
20020161332 Ramey Oct 2002 A1
20020161386 Halseth et al. Oct 2002 A1
20020165493 Bierman Nov 2002 A1
20020169419 Steg Nov 2002 A1
20020173748 McConnell et al. Nov 2002 A1
20020173769 Gray et al. Nov 2002 A1
20020183688 Lastovich et al. Dec 2002 A1
20020189688 Roorda Dec 2002 A1
20020193737 Popovsky Dec 2002 A1
20020193744 Alesi et al. Dec 2002 A1
20030014018 Giambattista et al. Jan 2003 A1
20030060781 Mogensen et al. Mar 2003 A1
20030069548 Connelly et al. Apr 2003 A1
20030088238 Poulsen et al. May 2003 A1
20030105430 Lavi et al. Jun 2003 A1
20030109829 Mogensen et al. Jun 2003 A1
20030125669 Safabash et al. Jul 2003 A1
20030125678 Swenson et al. Jul 2003 A1
20030130619 Safabash et al. Jul 2003 A1
20030139704 Lin Jul 2003 A1
20030158520 Safabash et al. Aug 2003 A1
20030176843 Wilkinson Sep 2003 A1
20030176852 Lynch et al. Sep 2003 A1
20030181863 Davis et al. Sep 2003 A1
20030181868 Swenson Sep 2003 A1
20030181873 Swenson Sep 2003 A1
20030181874 Bressler et al. Sep 2003 A1
20030187394 Wilkinson et al. Oct 2003 A1
20030187395 Wilkinson et al. Oct 2003 A1
20030199823 Bobroff et al. Oct 2003 A1
20030216686 Lynch et al. Nov 2003 A1
20030220610 Lastovich et al. Nov 2003 A1
20030225373 Bobroff et al. Dec 2003 A1
20030225374 Mathiasen Dec 2003 A1
20030229308 Tsals et al. Dec 2003 A1
20030229316 Hwang et al. Dec 2003 A1
20040002682 Kovelman et al. Jan 2004 A1
20040006316 Patton Jan 2004 A1
20040026840 Eckel et al. Feb 2004 A1
20040044306 Lynch et al. Mar 2004 A1
20040049159 Barrus et al. Mar 2004 A1
20040059316 Smedegaard Mar 2004 A1
20040068231 Blondeau Apr 2004 A1
20040069044 Lavi et al. Apr 2004 A1
20040087913 Rogers et al. May 2004 A1
20040092865 Flaherty et al. May 2004 A1
20040092875 Kochamba May 2004 A1
20040111068 Swenson Jun 2004 A1
20040112781 Hofverberg et al. Jun 2004 A1
20040116865 Bengtsson Jun 2004 A1
20040133164 Funderburk et al. Jul 2004 A1
20040138612 Shermer et al. Jul 2004 A1
20040138620 Douglas et al. Jul 2004 A1
20040143216 Douglas et al. Jul 2004 A1
20040143218 Das Jul 2004 A1
20040158202 Jensen Aug 2004 A1
20040158207 Hunn et al. Aug 2004 A1
20040162518 Connelly et al. Aug 2004 A1
20040171989 Horner et al. Sep 2004 A1
20040178098 Swenson et al. Sep 2004 A1
20040186446 Ohshima Sep 2004 A1
20040193143 Sauer Sep 2004 A1
20040199123 Nielsen Oct 2004 A1
20040204673 Flaherty et al. Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204690 Yashiro et al. Oct 2004 A1
20040215151 Marshall et al. Oct 2004 A1
20040220528 Garcia, Jr. Nov 2004 A1
20040236284 Hoste et al. Nov 2004 A1
20040238392 Peterson et al. Dec 2004 A1
20040243065 McConnell et al. Dec 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040260235 Douglas Dec 2004 A1
20040260250 Harris et al. Dec 2004 A1
20050035014 Cane Feb 2005 A1
20050038378 Lastovich et al. Feb 2005 A1
20050043687 Mogensen et al. Feb 2005 A1
20050049571 Lastovich et al. Mar 2005 A1
20050065466 Vedrine Mar 2005 A1
20050065472 Cindrich et al. Mar 2005 A1
20050075606 Botich et al. Apr 2005 A1
20050080386 Reid Apr 2005 A1
20050101910 Bowman et al. May 2005 A1
20050101912 Faust et al. May 2005 A1
20050101932 Cote et al. May 2005 A1
20050101933 Marrs et al. May 2005 A1
20050107743 Fangrow, Jr. May 2005 A1
20050113761 Faust et al. May 2005 A1
20050119611 Marano-Ford et al. Jun 2005 A1
20050119619 Haining Jun 2005 A1
20050119637 Lundgren et al. Jun 2005 A1
20050124936 Mogensen et al. Jun 2005 A1
20050131347 Marano-Ford et al. Jun 2005 A1
20050159709 Wilkinson Jul 2005 A1
20050159714 Gibson Jul 2005 A1
20050165382 Fulford Jul 2005 A1
20050192560 Walls et al. Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050215979 Kornerup et al. Sep 2005 A1
20050240154 Mogensen et al. Oct 2005 A1
20050251098 Wyss et al. Nov 2005 A1
20050256456 Marano-Ford et al. Nov 2005 A1
20050261629 Marano-Ford et al. Nov 2005 A1
20050277892 Chen Dec 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060015063 Butikofer et al. Jan 2006 A1
20060015076 Heinzerling et al. Jan 2006 A1
20060030815 Csincsura et al. Feb 2006 A1
20060036214 Mogensen et al. Feb 2006 A1
20060041224 Jensen Feb 2006 A1
20060069351 Safabash et al. Mar 2006 A9
20060069382 Pedersen Mar 2006 A1
20060069383 Bogaerts et al. Mar 2006 A1
20060095003 Marano-Ford et al. May 2006 A1
20060095014 Ethelfeld May 2006 A1
20060106346 Sullivan et al. May 2006 A1
20060129123 Wojcik Jun 2006 A1
20060135908 Liniger et al. Jun 2006 A1
20060135913 Ethelfeld Jun 2006 A1
20060142698 Ethelfeld Jun 2006 A1
20060161108 Mogensen et al. Jul 2006 A1
20060173410 Moberg et al. Aug 2006 A1
20060173413 Fan Aug 2006 A1
20060184104 Cheney, II et al. Aug 2006 A1
20060184140 Okiyama Aug 2006 A1
20060200073 Radmer et al. Sep 2006 A1
20060241551 Lynch et al. Oct 2006 A1
20060247553 Diermann et al. Nov 2006 A1
20060247574 Maule et al. Nov 2006 A1
20060253085 Geismar et al. Nov 2006 A1
20060253086 Moberg et al. Nov 2006 A1
20060264835 Nielsen et al. Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20070005017 Alchas et al. Jan 2007 A1
20070016129 Liniger et al. Jan 2007 A1
20070016159 Sparholt et al. Jan 2007 A1
20070021729 Mogensen et al. Jan 2007 A1
20070049865 Radmer et al. Mar 2007 A1
20070049870 Gray et al. Mar 2007 A1
20070066955 Sparholt et al. Mar 2007 A1
20070088271 Richards et al. Apr 2007 A1
20070093754 Mogensen Apr 2007 A1
20070104596 Preuthun et al. May 2007 A1
20070112301 Preuthun et al. May 2007 A1
20070112303 Liniger May 2007 A1
20070129688 Scheurer et al. Jun 2007 A1
20070173767 Lynch et al. Jul 2007 A1
20070179444 Causey et al. Aug 2007 A1
20070185441 Fangrow, Jr. Aug 2007 A1
20070191772 Wojcik Aug 2007 A1
20070191773 Wojcik Aug 2007 A1
20070203454 Shermer et al. Aug 2007 A1
20070213673 Douglas Sep 2007 A1
20070244448 Lastovich et al. Oct 2007 A1
20080312601 Cane′ Dec 2008 A1
20100004597 Gyrn et al. Jan 2010 A1
20100137829 Nielsen et al. Jun 2010 A1
20100228226 Nielsen Sep 2010 A1
Foreign Referenced Citations (234)
Number Date Country
893 296 Dec 1953 DE
1 053 541 Mar 1959 DE
26 20 009 Dec 1977 DE
28 03 509 Aug 1979 DE
28 03 509 Aug 1979 DE
37 15 965 Jan 1988 DE
4 342 329 Jun 1994 DE
196 31 921 Mar 1997 DE
298 18 311 Mar 1999 DE
299 05 072 Sep 1999 DE
298 18 311 Nov 1999 DE
19847143 Jan 2000 DE
101 06 074 Sep 2000 DE
299 21 406 Jan 2001 DE
101 06 074 Jun 2002 DE
101 17 285 Nov 2002 DE
299 21 406 Nov 2002 DE
203 20 207 Nov 2004 DE
DE 37 22 893 Jun 1988 DK
DE 38 23 447 Feb 1996 DK
DE 196 10 692 Sep 1997 DK
DE 198 47 143 Jan 2000 DK
DE 100 49 001 Apr 2002 DK
01176232 Sep 1984 EP
0 188 014 Oct 1985 EP
0 239 244 Feb 1987 EP
0272530 Jun 1988 EP
0 298 521 Sep 1990 EP
0451040 Oct 1991 EP
0 184 231 Jan 1992 EP
0 475 857 Mar 1992 EP
0 544 837 Jun 1993 EP
0 633 039 Jul 1994 EP
0615768 Sep 1994 EP
0 651 662 May 1995 EP
0652027 May 1995 EP
0657184 Jun 1995 EP
0 714 631 Jun 1996 EP
744 183 Nov 1996 EP
0 747 006 Dec 1996 EP
0799626 Oct 1997 EP
0 688 232 Dec 1998 EP
0 884 108 Dec 1998 EP
0 916 361 May 1999 EP
0 931 560 Jul 1999 EP
0937475 Aug 1999 EP
0 956 879 Nov 1999 EP
1 045 145 Oct 2000 EP
1 060 757 Dec 2000 EP
1 086 718 Mar 2001 EP
1 125 593 Aug 2001 EP
1 167 765 Jan 2002 EP
0 775 501 Jun 2002 EP
0 894 216 Jul 2003 EP
1329233 Jul 2003 EP
1350537 Oct 2003 EP
1360970 Nov 2003 EP
1 380 315 Jan 2004 EP
1407747 Apr 2004 EP
1407793 Apr 2004 EP
1421968 May 2004 EP
0 956 879 Jul 2004 EP
1177802 Sep 2004 EP
1475113 Nov 2004 EP
1495775 Jan 2005 EP
1502613 Feb 2005 EP
1525873 Apr 2005 EP
1527792 May 2005 EP
1616594 Jan 2006 EP
1704889 Sep 2006 EP
1762259 Mar 2007 EP
1764125 Mar 2007 EP
576 849 Aug 1924 FR
576849 Aug 1924 FR
2 611 013 Aug 1988 FR
2725902 Oct 1994 FR
2 733 915 Nov 1996 FR
2733915 Nov 1996 FR
2 752 164 Feb 1998 FR
2 781 617 Jan 2000 FR
2781617 Jan 2000 FR
478803 Jan 1938 GB
591730 Mar 1946 GB
906574 Sep 1962 GB
1 268 575 Mar 1972 GB
1 403 034 Aug 1975 GB
2 088 215 Jun 1982 GB
2 224 808 May 1990 GB
2 230 702 Oct 1990 GB
2 270 552 Mar 1994 GB
10179734 Aug 1991 JP
5326062 Dec 1993 JP
05326062 Dec 1993 JP
7051251 Nov 1995 JP
8187286 Jul 1996 JP
9217584 Sep 1997 JP
A-03-191965 Jul 1998 JP
2000-59877 Feb 2000 JP
3140740 Feb 2000 JP
2000059877 Feb 2000 JP
3140740 Mar 2001 JP
2002-028246 Jan 2002 JP
1017427 Nov 2002 NL
WO 8101795 Jul 1981 WO
WO 8203558 Oct 1982 WO
WO 8706474 Nov 1987 WO
WO 9204062 Mar 1992 WO
WO 9303787 Mar 1993 WO
WO 9305840 Apr 1993 WO
WO 9311709 Jun 1993 WO
WO 9420160 Sep 1994 WO
WO 9528327 Oct 1995 WO
WO 9632981 Jul 1996 WO
WO 9620021 Oct 1996 WO
WO 9635472 Nov 1996 WO
WO 9809065 Mar 1998 WO
WO 9826835 Jun 1998 WO
WO 9833549 Aug 1998 WO
WO 9858693 Dec 1998 WO
WO 9907435 Feb 1999 WO
WO 9933504 Jul 1999 WO
WO 9936009 Jul 1999 WO
WO 9956802 Nov 1999 WO
WO 9961815 Dec 1999 WO
WO 0002614 Jan 2000 WO
WO 0003757 Jan 2000 WO
WO 0044324 Aug 2000 WO
WO 0104507 Jan 2001 WO
WO 0130419 May 2001 WO
WO 0168180 Sep 2001 WO
WO 0172353 Oct 2001 WO
WO 0176684 Oct 2001 WO
WO 0181785 Nov 2001 WO
WO 0193926 Dec 2001 WO
WO 0202165 Jan 2002 WO
WO 0207804 Jan 2002 WO
WO 0240083 May 2002 WO
WO 0246080 Jun 2002 WO
WO 02053220 Jul 2002 WO
WO 02066854 Aug 2002 WO
WO 02068014 Sep 2002 WO
WO 02081012 Oct 2002 WO
WO 02081013 Oct 2002 WO
WO 02083206 Oct 2002 WO
WO 02094352 Nov 2002 WO
WO 02100457 Dec 2002 WO
WO 02102442 Dec 2002 WO
WO 03015860 Feb 2003 WO
WO 03026728 Apr 2003 WO
WO 03068305 Aug 2003 WO
WO 03075980 Sep 2003 WO
WO 03095003 Nov 2003 WO
WO 2004012796 Feb 2004 WO
WO 2004029457 Apr 2004 WO
WO 2004030726 Apr 2004 WO
WO 2004037325 May 2004 WO
WO 2004054644 Jul 2004 WO
WO 2004056412 Jul 2004 WO
WO 2004064593 Aug 2004 WO
WO 2004071308 Aug 2004 WO
WO 2004087240 Oct 2004 WO
WO 2004098683 Nov 2004 WO
WO 2004101016 Nov 2004 WO
WO 2004101071 Nov 2004 WO
WO 2004110527 Dec 2004 WO
WO 2005002649 Jan 2005 WO
WO 2005004973 Jan 2005 WO
WO 2005018703 Mar 2005 WO
WO 2005037184 Apr 2005 WO
WO 2005037350 Apr 2005 WO
WO 2005039673 May 2005 WO
WO 2005046780 May 2005 WO
WO 2005065748 Jul 2005 WO
WO 2005068006 Jul 2005 WO
WO 2005072795 Aug 2005 WO
WO 2005092410 Oct 2005 WO
WO 2005094920 Oct 2005 WO
WO 2005118055 Dec 2005 WO
WO 2006003130 Jan 2006 WO
WO 2006015507 Feb 2006 WO
WO 2006015600 Feb 2006 WO
WO 2006024650 Mar 2006 WO
WO 2006032689 Mar 2006 WO
WO 2006032692 Mar 2006 WO
WO 2006061027 Jun 2006 WO
WO 2006061354 Jun 2006 WO
WO 2006062912 Jun 2006 WO
WO 2006075016 Jul 2006 WO
WO 2006077262 Jul 2006 WO
WO 2006077263 Jul 2006 WO
WO 2006089958 Aug 2006 WO
WO 2006097111 Sep 2006 WO
WO 2006108775 Oct 2006 WO
WO 2006120253 Nov 2006 WO
WO 2006121921 Nov 2006 WO
WO 2006122048 Nov 2006 WO
WO 2007000162 Jan 2007 WO
WO 2007002523 Jan 2007 WO
WO 2007020090 Feb 2007 WO
WO 2007065944 Jun 2007 WO
WO 2007071255 Jun 2007 WO
WO 2007071258 Jun 2007 WO
WO 2007093051 Aug 2007 WO
WO 2007093182 Aug 2007 WO
WO 2007122207 Nov 2007 WO
WO 2007140631 Dec 2007 WO
WO 2007140783 Dec 2007 WO
WO 2007140785 Dec 2007 WO
WO 2007141210 Dec 2007 WO
WO 2008014791 Feb 2008 WO
WO 2008014792 Feb 2008 WO
WO 2008048631 Apr 2008 WO
WO 2008052545 May 2008 WO
WO 2008092782 Aug 2008 WO
WO 2008092958 Aug 2008 WO
WO 2008092959 Aug 2008 WO
WO 2008135098 Nov 2008 WO
WO 2008148714 Dec 2008 WO
WO 2008155145 Dec 2008 WO
WO 2008155377 Dec 2008 WO
WO 2009004026 Jan 2009 WO
WO 2009007287 Jan 2009 WO
WO 2009010396 Jan 2009 WO
WO 2009010399 Jan 2009 WO
WO 2009098291 Aug 2009 WO
WO 2009098306 Aug 2009 WO
WO 2009101130 Aug 2009 WO
WO 2009101145 Aug 2009 WO
WO 2009103759 Aug 2009 WO
WO 2009106517 Sep 2009 WO
WO 2009144272 Dec 2009 WO
WO 2010003885 Jan 2010 WO
WO 2010003886 Jan 2010 WO
WO 2010034830 Apr 2010 WO
Related Publications (1)
Number Date Country
20060036214 A1 Feb 2006 US
Provisional Applications (1)
Number Date Country
60600209 Aug 2004 US